By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panel consensus is bearish on SUSS MicroTec, citing a severe cyclical downturn, weak demand from China, and concerns about the company's ability to defend its intellectual property in the AI backend space. The 87% dividend cut and FY26 margin guidance suggest cash preservation and a lack of immediate visibility into a rebound.
Risk: The single biggest risk flagged is the company's ability to defend its intellectual property against larger players in the AI backend space and the potential for giants to consolidate the market, turning SUSS into takeover fodder.
Opportunity: No significant opportunities were highlighted by the panel.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
(RTTNews) - SUSS MicroTec SE (SESMF, SMHN.F) shares were losing around 3 percent in Germany after the manufacturer of equipment and process solutions for the semiconductor industry on Monday reported lower earnings and orders for fiscal 2025, even though sales were higher. Further, the firm proposed a sharp decline in dividend.
In addition, the company issued outlook, expecing lower margin and sales in fiscal 2026, but growth in fiscal 2030.
For fiscal 2026, SUSS MicroTec guides lower sales of 425 million euros to 485 million euros, which, at the midpoint of the range, would represent a 9.6 percent decline compared to 2025. EBIT margin is expected to range between 8 percent and 10 percent for the full year, compared to 13.1 percent in fiscal 2025.
Further, by 2030, the company expects sales to rise to between 750 million euros and 900 million euros. The EBIT margin is expected to increase to 20 to 22 percent over the same period.
For the full year, SUSS MicroTec proposed a dividend of 0.04 euro per share, down from 0.30 euro per share last year.
For the financial year 2025, net profit declined to 46.107 million euros or 2.41 euros per basic share from 109.974 million euros or 5.75 euros per basic share last year. Earnings from continuing operations were 2.59 euros per basic share, compared to 2.70 euros per basic share last year.
EBIT climbed down 11.7 percent to 65.872 million euros from 74.614 million euros in the previous year. The EBIT margin amounted to 13.1 percent, compared to previous year's 16.7 percent.
EBITDA declined 5.7 percent to 77.7 million euros from 82.4 million euros in the prior year.
The German company's sales rose by 12.6 percent to 503.180 million euros from 446.654 million euros last year.
Order intake fell 16.4 percent from last year to 354.3 million euros, due to weaker order momentum in the first three quarters and a general decline in demand from Chinese customers.
Order book as of December 31 fell 37.8 percent to 266.8 million euros.
On the Frankfurt stock exchange, shares of SUSS MicroTec were down 3.27 percent in the morning trade, at 49.04 euros.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"The 37.8% order book collapse and explicit China weakness signal a demand reset that will persist through FY26, making near-term recovery uncertain despite long-term optimism."
SUSS MicroTec (SMHN.F) is signaling a demand cliff, not a cyclical dip. FY26 guidance of 425–485M EUR (−9.6% YoY) with EBIT margin compression to 8–10% from 13.1% is severe. The 37.8% order book collapse and 16.4% order intake drop, driven explicitly by Chinese customer weakness, suggests the semiconductor equipment cycle has rolled over faster than the market priced in. However, the 2030 guidance (750–900M EUR, 20–22% EBIT margin) implies management believes this is temporary. The dividend cut (0.04 from 0.30 EUR) is the real tell: cash preservation, not confidence.
If Chinese demand truly collapsed, why is management guiding to 2030 growth and margin expansion at all? That confidence could reflect real visibility into post-2026 recovery cycles or new product cycles the article doesn't detail.
"The collapse of the order book by nearly 38% and a slashed dividend indicate that the FY26 downturn will be deeper and more painful than the market currently anticipates."
SUSS MicroTec (SMHN.F) is signaling a severe cyclical downturn, with FY26 sales guidance of €425M-€485M marking a ~10% drop and EBIT margins compressing from 13.1% to a dismal 8-10%. The 87% dividend cut (from €0.30 to €0.04) is a defensive liquidity move that suggests management sees no immediate floor. The 16.4% drop in order intake and a 37.8% collapse in the order book are the real red flags, driven by waning Chinese demand. While the 2030 targets of €750M+ sales and 20% margins sound ambitious, they are too distant to offset the immediate risk of a multi-year 'valley' in semiconductor capital equipment spending.
The 2030 guidance suggests a massive pivot toward advanced packaging and AI-related lithography, meaning the current sell-off might be an overreaction to a temporary transition period. If the company is clearing the decks of old Chinese legacy orders to make room for higher-margin AI business, the FY26 dip is a strategic reset rather than a structural failure.
"N/A"
[Unavailable]
"Shrinking order book and FY26 downside guide amid China weakness signal multi-quarter semi equipment pain, justifying derating from 20x FY25 EPS."
SUSS MicroTec's FY25 sales rose 13% to €503M, but EBIT margins crushed to 13.1% from 16.7% amid cost pressures, with orders cratering 16% to €354M and backlog plunging 38% to €267M—blaming China demand slump. FY26 guide screams caution: sales drop 10% midpoint to €455M, margins to 8-10%, dividend gutted 87% to €0.04/share for cash hoard. At 49€, ~20x FY25 EPS (2.41€) but FY26 implied ~17x on €2.7 guide—exposed to semi cycle trough, China risks, no quick rebound visibility. Long-term FY30 €825M sales/21% margins visionary but years away.
If AI-fueled backend lithography demand (SUSS's niche) ignites earlier than FY30, crushing FY26 guide, this order drought becomes a classic cycle bottom with 10%+ CAGR baked in at a steal.
"FY26 margin compression may signal strategic repositioning toward higher-margin AI products, not cyclical weakness—but the article provides zero product-level detail to confirm this."
Grok flags the valuation math (20x FY25 EPS compressing to 17x FY26), but nobody's interrogated whether that compression is *deserved*. If SUSS is truly pivoting to AI backend lithography—higher-margin, less China-exposed—then FY26 is intentionally sacrificed margin to reset the customer mix. That would make 8-10% EBIT a floor, not a death spiral. The 2030 targets only make sense if management has visibility into that transition. What's the actual product mix shift?
"The FY26 margin compression is likely a deliberate R&D-heavy transition toward high-margin AI packaging rather than a structural collapse."
Claude and Gemini are overstating the 'China slump' as a cyclical death knell while ignoring the 2030 guidance as a valuation anchor. If management expects a 20%+ EBIT margin by 2030, they aren't just 'clearing the decks'—they are likely investing heavily in R&D for hybrid bonding and advanced packaging now. This explains the 8-10% margin floor in FY26. The real risk isn't China; it's whether SUSS can defend its IP against larger players like ASML or Applied Materials in the AI backend space.
"2030 guidance is aspirational and doesn't validate FY26 as a deliberate strategic reset because backlog quality and cancellation risk leave near-term demand visibility weak."
Management’s 2030 target shouldn’t be read as hard visibility into a post‑2026 rebound. Long‑range targets are often strategic aspirations; they don’t change immediate economics: backlog plunged 38% to €267m and order intake is down 16% — yet we lack disclosure on backlog convertibility or cancellation rights. The 87% dividend cut and FY26 margin guidance look like cash preservation against real demand risk, not evidence FY26 is a planned strategic reset.
"SUSS's minuscule scale vs. semi giants erodes its AI packaging moat, amplifying competitive risks beyond China."
Gemini downplays China while hyping R&D for hybrid bonding, but ignores SUSS's razor-thin moat: €503M rev dwarfs AMAT ($27B) or ASML ($30B+). No evidence of defensible IP in backend lithography—FY25 margin crush despite sales growth screams execution weakness. FY26's 8-10% EBIT is no floor if giants consolidate the AI pivot, turning SUSS into takeover fodder.
The panel consensus is bearish on SUSS MicroTec, citing a severe cyclical downturn, weak demand from China, and concerns about the company's ability to defend its intellectual property in the AI backend space. The 87% dividend cut and FY26 margin guidance suggest cash preservation and a lack of immediate visibility into a rebound.
No significant opportunities were highlighted by the panel.
The single biggest risk flagged is the company's ability to defend its intellectual property against larger players in the AI backend space and the potential for giants to consolidate the market, turning SUSS into takeover fodder.